These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30259904)

  • 1. Toward the Development of Novel Therapy for Hypertrophic Cardiomyopathy.
    Matsuura K
    Int Heart J; 2018; 59(5):914-916. PubMed ID: 30259904
    [No Abstract]   [Full Text] [Related]  

  • 2. Energy utilization of induced pluripotent stem cell-derived cardiomyocyte in Fabry disease.
    Chou SJ; Yu WC; Chang YL; Chen WY; Chang WC; Chien Y; Yen JC; Liu YY; Chen SJ; Wang CY; Chen YH; Niu DM; Lin SJ; Chen JW; Chiou SH; Leu HB
    Int J Cardiol; 2017 Apr; 232():255-263. PubMed ID: 28082092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'End-stage' hypertrophic cardiomyopathy: from mystery to model.
    Yacoub MH; Olivotto I; Cecchi F
    Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):232-3. PubMed ID: 17457348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heart failure associated with hypertrophic cardiomyopathy].
    Oka N; Ohmura H; Ueda T
    Nihon Rinsho; 2007 May; 65 Suppl 5():425-9. PubMed ID: 17569322
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bipolar disorder: advances in the prediction of lithium response and development of new therapies using induced pluripotent stem cells].
    Santos R; Charnay P
    Med Sci (Paris); 2017 Dec; 33(12):1048-1050. PubMed ID: 29261491
    [No Abstract]   [Full Text] [Related]  

  • 6. Indicators and treatment of hypertensive heart disease.
    Weir MR
    Hosp Pract (1995); 1999 Sep; 34(9):93-4, 99-100, 103-4 passim. PubMed ID: 10901763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The time has come of a therapeutic (re)positioning of the ultra-rare diseases].
    Martinat C; Peschanski M
    Med Sci (Paris); 2018 Dec; 34(12):1019-1021. PubMed ID: 30623755
    [No Abstract]   [Full Text] [Related]  

  • 8. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging.
    Olivotto I; Cecchi F; Poggesi C; Yacoub MH
    Circ Heart Fail; 2012 Jul; 5(4):535-46. PubMed ID: 22811549
    [No Abstract]   [Full Text] [Related]  

  • 9. [Criteria of treatment and prognosis in hypertrophic obstructive cardiomyopathy, obtained from electrocardiographic and catamnestic studies].
    Di Paolo E; Baldi G; Villecco AS
    Boll Soc Ital Cardiol; 1978; 23(9):1501-3. PubMed ID: 45250
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apical hypertrophic cardiomyopathy as a cause of cardiac insufficiency in an 84-year-old woman--a case report].
    Grabysa R
    Kardiol Pol; 2008 Feb; 66(2):179-82. PubMed ID: 18344156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When the heart in trouble is a young one.
    Dulak SB
    RN; 2006 May; 69(5):24ac1-5; quiz 24ac6. PubMed ID: 16722262
    [No Abstract]   [Full Text] [Related]  

  • 12. [Up-date in the field of hypertrophic cardiomyopathy].
    Recalcati F; Negri M; Belli C
    G Ital Cardiol; 1985 Sep; 15(9):903-15. PubMed ID: 2867945
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible hypertrophic cardiomyopathy associated with nesidioblastosis.
    Harris JP; Ricker AT; Gray RS; Steed RD; Gutai JJ
    J Pediatr; 1992 Feb; 120(2 Pt 1):272-5. PubMed ID: 1735827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants of cardiomyopathy and hypertension in neuroblastoma.
    Kwok SY; Cheng FW; Lo AF; Leung WK; Yam MC; Li CK
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):e158-61. PubMed ID: 23652880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.
    Dalzell JR; Connolly EC; Cannon JA
    J Am Coll Cardiol; 2020 Oct; 76(16):1912. PubMed ID: 32805349
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply: The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron BJ; Maron MS
    J Am Coll Cardiol; 2020 Oct; 76(16):1913. PubMed ID: 32805353
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy and outflow tract obstruction.
    Iqbal K; Tramboo NA; Mohi-Ud-Din K
    N Engl J Med; 2003 May; 348(18):1815-6; author reply 1815-6. PubMed ID: 12728915
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressively worsening hypertrophic cardiomyopathy in a child with newly diagnosed Costello syndrome while receiving growth hormone therapy.
    Kobayashi D; Cook AL; Williams DA
    Cardiol Young; 2010 Aug; 20(4):459-61. PubMed ID: 20307337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated left ventricular non-compaction: an unusual indication for heart transplantation.
    Fan KY; Chan CW; Cheng LC; Ko RL; Lam YM; Jim MH; Au TW; Ho CK; Wang EP; Chau EM; Chow WH
    Hong Kong Med J; 2009 Oct; 15(5):378-80. PubMed ID: 19801696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human induced pluripotent stem cells: A disruptive innovation.
    De Vos J; Bouckenheimer J; Sansac C; Lemaître JM; Assou S
    Curr Res Transl Med; 2016; 64(2):91-6. PubMed ID: 27316392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.